IQCJ Inhibitors
IQCJ inhibitors belong to a class of chemical compounds designed to target and interfere with the activity of a molecule known as IQCJ, or IQ motif-containing protein J. These inhibitors are developed to modulate the function of IQCJ, which may be involved in a range of biological processes, including cellular signaling, molecular interactions, or structural functions.
The primary mechanism of action for IQCJ inhibitors typically involves their interaction with the IQCJ protein or its associated molecules, leading to the disruption of its normal function. By inhibiting IQCJ, these compounds have the to impact cellular processes under its control, although the specific functions of IQCJ are still being explored by researchers in the field. Researchers studying IQCJ inhibitors aim to unravel the specific roles and functions of IQCJ in cellular biology, contributing to our understanding of its significance within cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can bind to estrogen receptors, potentially affecting gene transcription regulation and possibly influencing IQCJ expression indirectly. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C forms crosslinks between DNA strands, which can impede DNA transcription and potentially reduce IQCJ mRNA levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus binds to FKBP12 and inhibits mTOR, which may downregulate protein synthesis globally, including that of IQCJ. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can disrupt downstream signaling, potentially leading to altered transcription and reduced IQCJ expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125 inhibits JNK signaling, which may affect transcription factor activity and potentially downregulate IQCJ gene expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK, which may alter MAPK signaling pathways and potentially decrease transcription of IQCJ. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially altering the signaling pathways that regulate gene expression, including that of IQCJ. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK1, which could modulate the MAPK/ERK pathway affecting transcription machinery, possibly impacting IQCJ expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts protein transportation within the cell, which may affect the stability and expression of various proteins including IQCJ. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 is a proteasome inhibitor which may cause an increase in misfolded proteins, potentially affecting cellular mechanisms regulating IQCJ expression. | ||||||